Bioscience, Biotechnology, and Biochemistry
Online ISSN : 1347-6947
Print ISSN : 0916-8451
Effects of Bifidobacterium longum BB536 Administration on Influenza Infection, Influenza Vaccine Antibody Titer, and Cell-Mediated Immunity in the Elderly
Kazuyoshi NAMBAMichiko HATANOTomoko YAESHIMAMitsunori TAKASEKunihiko SUZUKI
著者情報
ジャーナル フリー 早期公開

論文ID: 90749

詳細
抄録

Twenty-seven elderly subjects (mean age 86.7±6.6 years) were pre-administered a test food containing 1×1011 cfu of BB536 daily for 5 weeks (P1), during which they also received influenza vaccination at week 3. The subjects were then randomized to a BB536 group and a placebo group for 14 weeks (P2). The proportion of subjects who contracted influenza was significantly lower in BB536 group than in the to placebo group. The proportion of subjects with fever was also significantly lower in the BB536 group than in the placebo group. In the P1 period, the NK cell activity and the bactericidal activity of the neutrophils were significantly higher at week 5 than to before BB536 administration. In the P2 period, although NK cell activity and neutrophilic activities declined at the end of the study in both the placebo and the BB536 group, neutrophil phagocytic activity and NK cell activity tended to maintain slightly higher levels in the BB536 group than in the placebo group. These results suggest that continuous ingestion of BB536 reduces the incidence of influenza and fever, probably by potentiating innate immunity.

著者関連情報

この記事は最新の被引用情報を取得できません。

© 2010 by Japan Society for Bioscience, Biotechnology, and Agrochemistry
feedback
Top